---
schema_version: "secwatch.filing_event.v1"
accession: "0000920148-23-000078"
form_type: "8-K"
ticker: "LH"
cik: "0000920148"
company_name: "LABCORP HOLDINGS INC."
filed_at: "2023-10-26T23:59:59+00:00"
generated_at: "2026-06-09T09:29:24.650372+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Labcorp Q3 revenue up 6.6% to $3.06B; adjusted EPS $3.38 vs $4.01 YoY; narrows full-year guidance

## Summary
- Q3 revenue $3.06B (+6.6% YoY); Base Business revenue grew 14.0% YoY, partially offset by lower COVID-19 testing.
- GAAP diluted EPS $2.11 vs $3.06 YoY; adjusted EPS $3.38 vs $4.01 YoY.
- Updated FY2023 guidance: adjusted EPS $13.25-$13.75 (midpoint unchanged), FCF $0.85-$0.95B excluding spin items.
- Signed multiple hospital lab agreements including Tufts Medicine, Providence Health, Legacy Health, and Baystate Health.
- Launched ATN Profile, a blood-based test combining three biomarkers to aid Alzheimer's diagnosis.

## SEC filing metadata
- accession: 0000920148-23-000078
- form_type: 8-K
- ticker: LH
- cik: 0000920148
- company_name: LABCORP HOLDINGS INC.
- filed_at: 2023-10-26T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/920148/000092014823000078/0000920148-23-000078-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/920148/000092014823000078/lh-20231026.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000920148-23-000078
- JSON: https://secwatch.observer/filing/0000920148-23-000078.json
- Plain text: https://secwatch.observer/filing/0000920148-23-000078.txt

## Key facts
- Earnings Releases
  LABCORP HOLDINGS INC. reported the third quarter ended September 30, 2023 results: revenue $3.06 billion, net income $183.6 million, EPS $2.11. Guidance reaffirmed.
  - Period: the third quarter ended September 30, 2023
  - Revenue: $3.06 billion
  - Net income: $183.6 million
  - EPS: $2.11
  - Guidance: reaffirmed
  - Result: reported results
  source text: Guidance • Third quarter revenue grew 6.6% versus last year as the Base Business grew 14.0%. Results from Continuing Operations for third quarter versus last year: ◦ Revenue: $3.06 billion versus $2.87 billion ◦ Diluted EPS: $2.11 versus $3.06 ◦ Adjusted EPS: $3.38 versus $4.01 ◦ Free Cash Flow: $170.6 million versus $170.2 million • Full-Year 2023 Guidance from
  evidence_url: https://www.sec.gov/Archives/edgar/data/920148/000092014823000078/0000920148-23-000078-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.